Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - Vaxart, Inc. | ex_102927.htm |
| 8-K - FORM 8-K - Vaxart, Inc. | avir20180111_8k.htm |
Exhibit 99.2
Filed by Aviragen Therapeutics, Inc.
Pursuant to Rule 425 under the Securities Act of 1933, as amended
And deemed filed pursuant to Rule 14a-12
Of the Securities Exchange Act of 1934, as amended
Subject Company: Aviragen Therapeutics, Inc.
Commission File No. for Registration
Statement on Form S-4: 333-222009
